Fortis Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,775
Closed -$82K 242
2022
Q2
$82K Buy
9,775
+3,000
+44% +$41.9K 0.05% 145
2022
Q1
$155K Buy
6,775
+1,000
+17% +$24.4K 0.09% 119
2021
Q4
$159K Hold
5,775
0.09% 107
2021
Q3
$161K Buy
5,775
+775
+16% +$22K 0.1% 106
2021
Q2
$147K Buy
+5,000
New +$151K 0.08% 116
2018
Q2
Sell
-5,365
Closed -$85K 306
2018
Q1
$85K Hold
5,365
0.05% 147
2017
Q4
$111K Sell
5,365
-5,365
-50% -$85.1K 0.07% 126
2017
Q3
$154K Hold
10,730
0.11% 75
2017
Q2
$186K Buy
+10,730
New +$129K 0.14% 68

Other funds holding BHC

Fortis Advisors's BHC Position: Q3 2022 in Review

Fortis Advisors sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 9,775 shares — an estimated $82K sold.

Fortis Advisors first reported a position in BHC in Q2 2017 and held it in 9 quarters. The position peaked at $186K in Q2 2017. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Fortis Advisors reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Fortis Advisors sold 9,775 Bausch Health shares in Q3 2022, an estimated $82K.
  • Fortis Advisors first reported a position in Bausch Health in Q2 2017 and held it in 9 quarters.
  • Fortis Advisors's Bausch Health position peaked at $186K in Q2 2017.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Fortis Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.